ASSESSMENT OF CHANGES IN QUALITY OF PREHOSPITAL TREATMENT OF PATIENTS WITH ACUTE CORONARY SYNDROME IN THE LAST FEW YEARS: LIS-1 VS LIS-3 REGISTRIES
https://doi.org/10.20996/1819-6446-2017-13-6-827-834
Abstract
Aim. To assess the changes in prehospital treatment of patients with acute coronary syndrome during the last years on the basis of the LIS-3 registry data.
Material and methods. Data of acute coronary syndrome hospital registry LIS-3 (2013-2015, n=397) and acute myocardial infarction hospital registry LIS-1 (2005-2007, n=1133) were used. To assess quality of prehospital treatment the fact of taking specific pharmacological groups of medications for primary and secondary cardiovascular diseases prevention was taken into consideration.
Results. Patients in the LIS-3 registry, in comparison with patients in the LIS-1 registry, more often took antiplatelet drugs (23.2% vs 15.7%, respectively; p<0.01) and statins (4.9% vs 2%, respectively; p<0.01). However, in general, the frequency of prescribing these groups of medications remained low. The use of medications of other pharmacological groups was comparable in patients of LIS-1 and LIS-3 registries (p>0.05). The quality of prehospital treatment did not differ significantly in survived and deceased patients of LIS-3 registry (p>0.05).
Conclusion. Only slight improvement in the quality of prehospital therapy in patients with acute coronary syndrome was revealed, mainly due to more frequent use of antiplatelet drugs and statins. It may be explained by poor detection of early forms of ischemic heart disease and underestimation of the importance of risk factors correction, both on the part of patients and on the part of physicians.
About the Authors
Yu. V. SemenovaRussian Federation
Yulia V. Semenova – MD, Post-Graduate Student
Petroverigskiy per. 10, Moscow, 10199
A. V. Zagrebelnyy
Russian Federation
Alexander V. Zagrebelnyy – MD, PhD, Senior Researcher, Department of Preventive Pharmacotherapy
Petroverigskiy per. 10, Moscow, 10199
N. P. Kutishenko
Russian Federation
Natalia P. Kutishenko – MD, PhD, Professor, Head of Laboratory for Pharmacoepidemiological Studies, Department of Preventive Pharmacotherapy
Petroverigskiy per. 10, Moscow, 10199
M. L. Ginzburg
Russian Federation
Moisey L. Ginsburg – MD, PhD, Head of Cardiology Department
Oktyabrskiy prospect. 338, Lyubertsy, Moscow Region, 140006
S. Yu. Martsevich
Russian Federation
Sergey Yu. Martsevich – MD, PhD, Professor, Head of Department of Preventive Pharmacotherapy
Petroverigskiy per. 10, Moscow, 10199
References
1. Steg P.G., James S.K., Atar D., et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2012;33(20):2569-619. doi: 10.1093/eurheartj/ehs215.
2. Roffi M., Patrono C., Collet J.P., et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2015;37(3):267-315. doi: 10.1093/eurheartj/ehv320.
3. Montalescot G., Sechtem U., Achenbach S., et al. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J. 2013;34(38):2949-3003. doi: 10.1093/eurheartj/eht296.
4. Yusuf S., Islam S., Chow C.K., et al. Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey. Lancet (London, England). 2011;378(9798):1231-43. doi: 10.1016/S0140-6736(11)61215-4.
5. Erlich A.D., Gratsiansky N.A. Treatment specifics and clinical outcomes in patients with acute coronary syndrome and anaemia: RECORD registry Results. Russian Journal of Cardiology. 2012;97(5):12-6 (In Russ.) [Эрлих А.Д., Грацианский Н.А. Особенности лечения и исходы у больных с острым коронарным синдромом и анемией. Регультаты регистра РЕКОРД. Российский Кардиологический Журнал. 2012;97(5):12-6]. doi: 10.15829/1560-4071-2012-5-12-16.
6. Martsevich S.Y., Ginzburg M.L., Kutishenko N.P., et al. The LIS study (Lyubertsy study of mortality in patients with acute myocardial infarction). Evaluation of the pharmacotherapy. Part 1. Treatment of patients before myocardial infarction and its influence on hospital mortality rate. Rational Pharmacotherapy in Cardiology. 2012;8(5):681-4. (In Russ.) [Марцевич С.Ю., Гинзбург М.Л., Кутишенко Н.П., и др. Исследование ЛИС (Люберецкое исследование смертности больных, перенесших острый инфаркт миокарда). Оценка лекарственной терапии. Часть 1. Как лечатся больные перед инфарктом миокарда, и как это влияет на смертность в стационаре. Рациональная Фармакотерапия в Кардиологии. 2012;8(5):681-4]. doi: 10.20996/1819-6446-2012-8-5-681-684.
7. Martsevich S.Yu., Ginsburg M.L., Kutishenko N.P., et al. LIS Study (Lyubertsy Study of mortality in patients after acute myocardial infarction): the patients' portrait. Cardiovascular Therapy and Prevention. 2011;10(6):89-93. (In Russ.) [Марцевич С.Ю., Гинзбург М.Л., Кутишенко Н.П. и др. Исследование ЛИС (Люберецкое исследование смертности больных, перенесших острый инфаркт миокарда): портрет заболевшего. Кардиоваскулярная Терапия и Профилактика. 2011;10(6):89-93].
8. Martsevich S.Yu., Ginzburg M.L., Kutishenko N.P., et al. Lubertsy study of the mortality of patients who underwent an acute myocardial infarction (LIS): anamnestic factors determining death in a hospital. Cardiovascular Therapy and Prevention. 2012; 11 (1): 45-8 (In Russ.) [Марцевич С.Ю., Гинзбург М.Л., Кутишенко Н.П., и др. Люберецкое исследование смертности больных, перенесших острый инфаркт миокарда (ЛИС): анализ анамнестических факторов, определяющих смерть в стационаре. Кардиоваскулярная Терапия и Профилактика. 2012;11(1):45-8].
9. Martsevich S.Yu., Ginzburg M.L., Kutishenko N.P., et al. The Lyubertsy mortality study (LIS study): factors affecting the long-term prognosis of life after a heart attack. Profilakticheskaja Medicina. 2013; 16 (2): 32-8. (In Russ.) [Марцевич С.Ю., Гинзбург М.Л., Кутишенко Н.П., и др. Люберецкое исследование смертности (исследование ЛИС): факторы, влияющие на отдаленный прогноз жизни после перенесенного инфаркта миокарда. Профилактическая Медицина. 2013;16(2):32-8].
10. Martsevich S.Y., Semenova Y.V., Kutishenko N.P., et al. LIS-3 register of the acute coronary syndrome: what has changed in a "portrait" of a patient and short-term outcomes of the disease compared to LIS-1 register. Rational Pharmacotherapy in Cardiology. 2017;13(1):63-8. (In Russ.) [Марцевич С.Ю., Семенова Ю.В., Кутишенко Н.П., и др. Регистр острого коронарного синдрома ЛИС-3: что изменилось за прошедшие годы в «портрете» больного и ближайших исходах заболевания в сравнении с регистром ЛИС-1. Рациональная фармакотерапия в кардиологии. 2017;13(1):63-8]. doi: 10.20996/1819-6446-2017-13-1-63-68.
11. Semenova Y.V., Kutishenko N.P., Zagrebelnyy A.V., et al. Adherence to attendance at outpatient clinic, quality of prehospital therapy, and direct outcome of acute coronary syndrome: analysis within LIS3 registry. Rational Pharmacotherapy in Cardiology. 2016;12(4):430-4. (In Russ.) [Семенова Ю.В., Кутишенко Н.П., Загребельный А.В., и др. Приверженность к посещению лечебно-профилактических учреждений, качество терапии и ближайшие исходы острого коронарного синдрома: исследование в рамках регистра ЛИС-3. Рациональная Фармакотерапия в Кардиологии. 2016;12(4):430-4]. doi: 10.20996/1819-6446-2016-12-4-430-434.
12. Martsevich S.Y., Semenova Y.V., Kutishenko N.P., et al. Awareness of cardiovascular disease, its risk factors, and its association with attendance at outpatient clinics in acute coronary syndrome patients. Integr Med Res. 2017;6(3):240-4. doi: 10.1016/j.imr.2017.06.003
Review
For citations:
Semenova Yu.V., Zagrebelnyy A.V., Kutishenko N.P., Ginzburg M.L., Martsevich S.Yu. ASSESSMENT OF CHANGES IN QUALITY OF PREHOSPITAL TREATMENT OF PATIENTS WITH ACUTE CORONARY SYNDROME IN THE LAST FEW YEARS: LIS-1 VS LIS-3 REGISTRIES. Rational Pharmacotherapy in Cardiology. 2017;13(6):827-834. (In Russ.) https://doi.org/10.20996/1819-6446-2017-13-6-827-834